---
title: "Moderna 旗下实验性流感疫苗后期试验结果正面"
description: "Moderna 宣布其基于 mRNA 的实验性流感疫苗在后期试验中显示出比现有疫苗更强的免疫反应，股价盘前上涨逾 3%。公司计划在今年稍后重新提交联合疫苗的申请，并申请独立流感疫苗的批准，若获监管机构批准，将推动联合疫苗的研发。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/246684717.md"
published_at: "2025-06-30T12:38:09.000Z"
---

# Moderna 旗下实验性流感疫苗后期试验结果正面

> Moderna 宣布其基于 mRNA 的实验性流感疫苗在后期试验中显示出比现有疫苗更强的免疫反应，股价盘前上涨逾 3%。公司计划在今年稍后重新提交联合疫苗的申请，并申请独立流感疫苗的批准，若获监管机构批准，将推动联合疫苗的研发。

Moderna(MRNA.US) 周一表示，其基於 mRNA 的实验性流感疫苗在後期试验中显示比目前可用的疫苗更强的免疫反应，为该产品以及该公司单独的流感和新冠疫苗组合的发展铺路。该股股价盘前升逾 3%。

公司表示，在新数据下，计划在今年稍後重新提交联合疫苗的申请，并申请批准其独立的流感疫苗。若监管机构批准流感疫苗，该公司就可以推动联合疫苗的研发。

### Related Stocks

- [MRNA.US - Moderna](https://longbridge.com/zh-CN/quote/MRNA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| EMA's CHMP Recommended Granting Marketing Authorisation For Moderna's Mnexspike | EMA's CHMP recommended marketing authorisation for Moderna's Mnexspike for COVID-19 prevention in individuals aged 12 an | [Link](https://longbridge.com/zh-CN/news/269540340.md) |
| Moderna receives $54.3M investment for bird flu vaccine, covering axed federal mRNA contracts | Moderna has secured up to $54.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to fund its bird | [Link](https://longbridge.com/zh-CN/news/270158044.md) |
| Brazil's Copasa says bookrunners tapped for potential privatization share offering | Companhia de Saneamento de Minas Gerais Copasa MG :BTG PACTUAL, ITAU BBA, BOFA, CITI AND UBS BB TAPPED AS BOOKRUNNERS OF | [Link](https://longbridge.com/zh-CN/news/276494934.md) |
| BlackBarn, VR Global Partners raise stake in Brazil's Azul | Azul (AZUL53.SA):BLACKBARN REACHED 8.1% STAKE IN AZUL'S COMMON SHARES - FILINGBRAZIL'S AZUL: VR GLOBAL PARTNERS REACHED  | [Link](https://longbridge.com/zh-CN/news/276493947.md) |
| Cruise operator Carnival to unify dual listing | Carnivalannounced plans to unify its dual listings in New York and London and redomicile to Bermuda. The UK-listed Carni | [Link](https://longbridge.com/zh-CN/news/276491689.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。